Kinea Bio, Inc.
PrivateLast Round
Grant
Sep 23, 2025
Total Funding Raised
$3.94M
Company Overview
Kinea Bio, Inc. is a biotechnology company that develops next-generation AAV-based gene therapies to treat neuromuscular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kinea Bio, Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Kinea Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 23, 2025 | ||||
| Grant | Sep 15, 2025 | ||||
| Grant | Jun 9, 2025 | ||||
| Grant | Sep 10, 2024 | ||||
| Seed | Feb 13, 2024 |
Key People
Founding team and executive leadership
Kinea Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Parent Project Muscular Dystrophy | Seed |
| NIH RADx | Grant |
| The Jain Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 22, 2026
Monthly visitors increased 111% MoM, reaching 2.3K.
- Jun 9, 2025
Secured $2M from NIH RADx.
Kinea Bio, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kinea Bio, Inc.'s valuation, stock price, and market status.